InsiderTrades

Form 4 for HNGE Hinge Health, Inc.

Accepted 2025-12-12 00:00:00 ET · period of report 2025-12-10 · accession 0002063236-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-12 2025-12-12 HNGE Perez Daniel Antonio CEO, Co-Founder, Dir, 10% G - Gift $0.00 -11.7K 0 -100% $0
D 2025-12-12 2025-12-10 HNGE Perez Daniel Antonio CEO, Co-Founder, Dir, 10% C - Cnv Deriv $0.00 +11.7K 11.7K New $0
D 2025-12-12 2025-12-10 HNGE Perez Daniel Antonio CEO, Co-Founder, Dir, 10% C - Cnv Deriv $0.00 -11.7K 14.71M -0.1% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-12-12 G D 11,680 $0.00 0 D — —
2 Common Class A Common Stock 2025-12-10 C A 11,680 $0.00 11,680 D — —
3 Derivative Class B Common Stock 2025-12-10 C D 11,680 $0.00 14,710,097 D — · — to — 11,680 Class A Common Stock (F1) Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.